ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OBI Ondine Biomedical Inc.

7.00
-0.75 (-9.68%)
31 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Ondine Biomedical Inc. LSE:OBI London Ordinary Share CA68234M2058 COM SHS NPV (CDI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.75 -9.68% 7.00 7.00 8.00 7.75 7.50 7.75 80,025 16:35:28
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 638k -19.37M -0.0996 -0.75 14.59M
Ondine Biomedical Inc. is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker OBI. The last closing price for Ondine Biomedical was 7.75p. Over the last year, Ondine Biomedical shares have traded in a share price range of 4.50p to 16.50p.

Ondine Biomedical currently has 194,584,524 shares in issue. The market capitalisation of Ondine Biomedical is £14.59 million. Ondine Biomedical has a price to earnings ratio (PE ratio) of -0.75.

Ondine Biomedical Share Discussion Threads

Showing 901 to 920 of 1125 messages
Chat Pages: 45  44  43  42  41  40  39  38  37  36  35  34  Older
DateSubjectAuthorDiscuss
03/5/2024
09:20
Have you bought any jet Jailbird..I've only bought a token commitment for now.
marvelman
03/5/2024
09:17
We keep thinking one more funding will do it , then they mention another will be needed .Would expect the strike price to be higher though next time
jailbird
03/5/2024
09:12
these will bag and some on phase 3 funding completion which is near term

nows the time to get in gl

purple11
03/5/2024
09:10
I want this company to succeed for the groundbreaking product.

However, investors may be waiting a long time for it to reach profitability. A further fundraising has been indicated and with these things there might yet be several more as the company does smaller placements along the way.

I'm interested but will wait it out as the risks are still high and the US P3 results once funding is obtained might be 18 months to 24 months away.

hj996
03/5/2024
09:08
When we get further news regarding the phase 3 trials that's when the share price will really take off.

From the latest rns:

The net proceeds of the Fundraising will be used for general working capital, US Phase 3 Clinical Trial readiness and start-up preparation, and to support the Company's rapid sales growth of its Steriwave® nasal decolonisation therapy.

z1co
03/5/2024
08:53
Not sure why it uses so much cash , with potential further cash needed this year Excluding the Phase 3 clinical trial execution and related costs which are subject to further funding, the net proceeds of the Fundraising and strategic cost management will provide runway for the Company through to at least mid Q3 2024. This may be further extended through the issue of further New Common Shares in connection with future fundraisings, and/or the attainment of a higher value of commercial sales than is currently forecast.
jailbird
03/5/2024
08:51
purple113 May '24 - 08:06 - 327 of 327(premium)
0 0 2
in@5.50p gla

=========================================================

You're so pathetic no trades at 5.50p ,all trades are at 6p or above.

z1co
03/5/2024
08:47
Surprised at the muted reaction given the premium on the placing. Nevertheless its what we have been waiting for so its worth taking a chance now.
marvelman
03/5/2024
08:41
Great news , time to buy and hold for longer term now Did anyone last nights RNS? Owners had inject cash before raise
jailbird
03/5/2024
08:16
Discussions are underway with HCA Healthcare's investment arm, Health Insight Capital, for its funding support of the key Phase 3 clinical trial. The Company is confident in its ability to secure longer-term financing to execute its growth opportunities. The Company has received an indication of further support from its founder, CEO and substantial shareholder, Carolyn Cross, to provide additional near-term funding to extend the Company's runway should that be required prior to arranging funding for the Phase 3 clinical trial and working capital.
purple11
03/5/2024
08:13
Carolyn Cross, CEO of Ondine, said:

"We are pleased to have the support of existing and new investors through this fundraising which meets our near-term working capital needs and assists our rapid commercial growth rate. This funding will take us forward commercially and further our discussions with industry partners on our clinical, financial, and global distribution objectives. We believe that our product, Steriwave, is very well positioned to help hospitals meet their infection control objectives, reduce their antibiotic usage and combat AMR in what is expected to be a multibillion-dollar market. Our commercial efforts are benefitting from the growing support for pre-surgical nasal decolonisation by leading organisations, as well as our real-world clinical successes in Canadian hospitals and adoption in other approved territories.



While we are currently focused on nasal decolonisation to prevent healthcare-associated infections, Steriwave is just the first of seven major market opportunities for our platform technology. In due course, pipeline products targeting the treatment of burns, wounds, chronic sinusitis, ventilator-associated pneumonia, and fungal infections will leverage our regulatory filings and the clinical successes related to our nasal decolonisation product."

purple11
03/5/2024
08:10
in today @6p
purple11
03/5/2024
08:06
Bought this morning
premium beeks
01/5/2024
13:39
not a very nice fellow is he?

how many times has he exited on his ramps leaving others to hold the baby?

nasty bit of work and a terrible stock picker.


READER BEWARE

purple11
01/5/2024
12:10
Read the thread i sold out at a profit and waiting to buy again.

Now go f#ck yourself.

WOW the thicko is a bellend

z1co
01/5/2024
11:44
ZICO THE CLOWN strikes again

halved since his buy in tip

it really is pot luck with this guy.His losers seem to far outweigh his odd winner

READER BEWARE

purple11
26/4/2024
15:42
OND does in fact face competion, e.g Destiny's XF-73 is equaly effective, also immune to the issue of resistance, and doesn't require a machine to activate it. Still, if I waa surgeon I might prefer OND's approach just because you can be 100% sure of compliance, though as a patient I would probably prefer XF-73.

When it comes to outpatient treatments for the prevention or treatment of infected wounds/ulcers etc which both companies are targetting in the more distant future, Destiny's products would appear to address a much larger market because, they can be applied outside a clinical setting, e.g at home, horses for courses.

banshee
26/4/2024
11:23
"You should know that I have spent much of last year on my back ith a femur in shards screwed back together waiting for the bone to regrow. How could you know much sbout preaching from time spent behind bars?"

Now how would I know that?

I left you at CPX with your tail between your legs

Wish u a full recovery, health is wealth

jailbird
26/4/2024
11:08
apologies to others for duplex post
scrutable
26/4/2024
11:07
jailbird
You should know that I have spent much of last year on my back with a femur in shards screwed back together waiting for the bone to regrow. How could you know much sbout preaching from time spent behind bars?

The Bishop from the cathedral opposite my bedroom wundow in Exeter would never offer you his pulpit. It must be obvious to you, even though you are probably no longer in Clink why I am excited by photo disinfecton.

scrutable
Chat Pages: 45  44  43  42  41  40  39  38  37  36  35  34  Older